-
NMPA holds meeting on vaccine regulatory QMS
2026-06-29
To advance the development of China's National Regulatory Authority (NRA) for vaccines and further enhance the country's vaccine regulatory capacity, the National Medical Products Administration (NMPA) held a working meeting on the development of the vaccine regulatory quality management system (QMS) in Changzhou, Jiangsu province, on June 12.
-
Yang Sheng meets with Danish ambassador and chairman of Novo Nordisk
2026-06-17
Yang Sheng, deputy commissioner of the National Medical Products Administration (NMPA), held talks with Michael Christensen, Denmark's ambassador to China, and Lars Sorensen, chairman of Danish global pharma group Novo Nordisk, on June 15 in Beijing.
-
Yang Sheng meets with Australian ambassador to China
2026-06-12
Yang Sheng, deputy commissioner of the National Medical Products Administration (NMPA), met with a delegation led by Scott Dewar, Australian ambassador to China, on June 4 in Beijing.
-
China updates drug clinical trial guideline to enhance biotech innovation
2026-06-12
China has recently released a new edition of the Good Clinical Practice for Drugs — a guideline designed to ensure the ethical and scientific conduct of clinical studies, aiming to enhance the nation's research ecosystem and support innovation in biotechnology.
-
Huang Guo meets with WHO representative to China
2026-06-01
Huang Guo, commissioner of the National Medical Products Administration (NMPA), met on May 27 in Beijing with a delegation led by Martin Taylor, World Health Organization (WHO) representative to China.
-
Huang Guo meets with Singaporean health authority CEO
2026-05-15
Huang Guo, commissioner of the National Medical Products Administration (NMPA), met in Beijing on May 11 with a delegation led by Raymond Chua Swee Boon, chief executive officer of the Health Sciences Authority (HSA) of Singapore.
